BACKGROUND: 5-Lipoxygenase (5-LO) catalyzes the rate-limiting step of the biosynthesis of proinflammatory leukotrienes from arachidonic acid (AA) and has been associated with atherosclerosis in animal models and humans. We previously reported that variants of a 5-LO promoter repeat polymorphism were associated with carotid atherosclerosis in humans, an effect that was exacerbated by high dietary AA but mitigated by high dietary n-3 fatty acids. OBJECTIVE: We sought to confirm these initial observations with a more clinically relevant phenotype such as myocardial infarction (MI). DESIGN: The 5-LO polymorphism was genotyped in 1885 Costa Rican case-control pairs and tested for association with MI. Functional experiments were carried out to determine whether the associated alleles had differences in mRNA expression. RESULTS: The frequency of variant genotype groups did not differ significantly between cases and controls. However, a significant gene x diet interaction was observed, in which, relative to the common 5 repeat allele, the 3 and 4 alleles were associated with a higher MI risk in the high (> or = 0.25 g/d) dietary AA group (odds ratio: 1.31; 95% CI: 1.07, 1.61) and with a lower risk in the low (<0. 25 g/d) AA group (0.77; 0.63, 0.94) (P for interaction = 0.015). Using allele-specific quantitation, the short alleles had expression approximately twice that of the 5 allele (P < 0.0001). CONCLUSIONS: The 3 and 4 variants lead to higher 5-LO expression and provide additional evidence that these alleles are associated with greater risks of atherosclerosis and MI in the context of a high-AA diet.
BACKGROUND:5-Lipoxygenase (5-LO) catalyzes the rate-limiting step of the biosynthesis of proinflammatory leukotrienes from arachidonic acid (AA) and has been associated with atherosclerosis in animal models and humans. We previously reported that variants of a 5-LO promoter repeat polymorphism were associated with carotid atherosclerosis in humans, an effect that was exacerbated by high dietary AA but mitigated by high dietary n-3 fatty acids. OBJECTIVE: We sought to confirm these initial observations with a more clinically relevant phenotype such as myocardial infarction (MI). DESIGN: The 5-LO polymorphism was genotyped in 1885 Costa Rican case-control pairs and tested for association with MI. Functional experiments were carried out to determine whether the associated alleles had differences in mRNA expression. RESULTS: The frequency of variant genotype groups did not differ significantly between cases and controls. However, a significant gene x diet interaction was observed, in which, relative to the common 5 repeat allele, the 3 and 4 alleles were associated with a higher MI risk in the high (> or = 0.25 g/d) dietary AA group (odds ratio: 1.31; 95% CI: 1.07, 1.61) and with a lower risk in the low (<0. 25 g/d) AA group (0.77; 0.63, 0.94) (P for interaction = 0.015). Using allele-specific quantitation, the short alleles had expression approximately twice that of the 5 allele (P < 0.0001). CONCLUSIONS: The 3 and 4 variants lead to higher 5-LO expression and provide additional evidence that these alleles are associated with greater risks of atherosclerosis and MI in the context of a high-AA diet.
Authors: Anna Helgadottir; Andrei Manolescu; Agnar Helgason; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Daniel F Gudbjartsson; Solveig Gretarsdottir; Kristinn P Magnusson; Gudmundur Gudmundsson; Andrew Hicks; Thorlakur Jonsson; Struan F A Grant; Jesus Sainz; Stephen J O'Brien; Sigurlaug Sveinbjornsdottir; Einar M Valdimarsson; Stefan E Matthiasson; Allan I Levey; Jerome L Abramson; Murdach P Reilly; Viola Vaccarino; Megan L Wolfe; Vilmundur Gudnason; Arshed A Quyyumi; Eric J Topol; Daniel J Rader; Gudmundur Thorgeirsson; Jeffrey R Gulcher; Hakon Hakonarson; Augustine Kong; Kari Stefansson Journal: Nat Genet Date: 2005-11-10 Impact factor: 38.330
Authors: Hong Qiu; Anders Gabrielsen; Hanna E Agardh; Min Wan; Anders Wetterholm; Chi-Huey Wong; Ulf Hedin; Jesper Swedenborg; Göran K Hansson; Bengt Samuelsson; Gabrielle Paulsson-Berne; Jesper Z Haeggström Journal: Proc Natl Acad Sci U S A Date: 2006-05-12 Impact factor: 11.205
Authors: Barry London; Christine Albert; Mark E Anderson; Wayne R Giles; David R Van Wagoner; Ethan Balk; George E Billman; Mei Chung; William Lands; Alexander Leaf; John McAnulty; Jeffrey R Martens; Rebecca B Costello; David A Lathrop Journal: Circulation Date: 2007-09-04 Impact factor: 29.690
Authors: Susan Sergeant; Christina E Hugenschmidt; Megan E Rudock; Julie T Ziegler; Priscilla Ivester; Hannah C Ainsworth; Dhananjay Vaidya; L Douglas Case; Carl D Langefeld; Barry I Freedman; Donald W Bowden; Rasika A Mathias; Floyd H Chilton Journal: Br J Nutr Date: 2011-07-04 Impact factor: 3.718
Authors: Patrice Armstrong; Darshan S Kelley; John W Newman; Frank E Staggers; Janna Hartiala; Hooman Allayee; Charles B Stephensen Journal: J Nutr Date: 2012-06-27 Impact factor: 4.798
Authors: Jinying Zhao; Mary J Roman; Richard B Devereux; Fawn Yeh; Ying Zhang; Karin Haack; Lyle G Best; Shelley A Cole; Elisa T Lee; Barbara V Howard Journal: Atherosclerosis Date: 2014-01-10 Impact factor: 5.162